PLIANT THERAPEUTICS, INC. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Pliant Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Pliant Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -48.9 %, a 50.5% decline year-over-year.
  • Pliant Therapeutics, Inc. annual Return On Equity for 2023 was -31.2 %, a 38.6% increase from 2022.
  • Pliant Therapeutics, Inc. annual Return On Equity for 2022 was -50.8 %, a 21% decline from 2021.
  • Pliant Therapeutics, Inc. annual Return On Equity for 2021 was -41.9 %, a 111% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -31.2 +19.6 +38.6% Jan 1, 2023 Dec 31, 2023
2022 -50.8 -8.81 -21% Jan 1, 2022 Dec 31, 2022
2021 -41.9 -22 -111% Jan 1, 2021 Dec 31, 2021
2020 -19.9 -20.6 -3117% Jan 1, 2020 Dec 31, 2020
2019 0.66 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.